Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity

Journal of Cell Biology

Volumn 191, Issue 7, 2010, Pages 1271-1283

  Hesse, Eric ^a,b   Saito, Hiroaki ^a,b   Kiviranta, Riku ^a,b   Correa, Diego ^a,b   Yamana, Kei ^a,b,c   Neff, Lynn ^a,b   Toben, Daniel ^d,e   Duda, Georg ^d,e   Atfi, Azeddine ^a,b   Geoffroy, Valérie ^f   Horne, William C ^a,b   Baron, Roland ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c TEIJIN PHARMA LIMITED   (Japan)

^d Center for Musculoskeletal Surgery   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 521;

ALLELE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MASS; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO; HOMEOSTASIS; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALKALINE PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CELL COUNT; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FRACTURES, SPONTANEOUS; GENE EXPRESSION; HETEROZYGOTE; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RANK LIGAND; RATS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

MUS; MUS MUSCULUS;

EID: 78650749107     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201009107     Document Type: Article

References (47)

1. Bialek, P., B. Kern, X. Yang, M. Schrock, D. Sosic, N. Hong, H. Wu, K. Yu, D.M. Ornitz, E.N. Olson, et al. 2004. A twist code determines the onset of osteoblast differentiation. Dev. Cell. 6:423-435. doi:10.1016/S1534-5807(04) 00058-9 (Pubitemid 38364573)
2. Bond, H.M., M. Mesuraca, E. Carbone, P. Bonelli, V. Agosti, N. Amodio, G. De Rosa, M. Di Nicola, A.M. Gianni, M.A.S. Moore, et al. 2004. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood. 103:2062-2070. doi: 10.1182/blood-2003-07-2388 (Pubitemid 38326221)
3. Bond, H.M., M. Mesuraca, N. Amodio, T. Mega, V. Agosti, D. Fanello, D. Pelaggi, L. Bullinger, M. Grieco, M. A. Moore, et al. 2008. Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells. Int. J. Biochem. Cell Biol. 40:848-854. doi:10.1016/j.biocel. 2007.04.006 (Pubitemid 351329659)
4. Chen, J., M.B. Kelz, G. Zeng, N. Sakai, C. Steffen, PE. Shockett, M.R. Picciotto, R.S. Duman, and E.J. Nestler. 1998. Transgenic animals with inducible, targeted gene expression in brain. Mol. Pharmacol. 54:495-503.
5. Compston, J.E. 2007. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure. Bone. 40:1447-1452. doi: 10,1016/j.bone.2006.09.008
6. Correa, D., E. Hesse, D. Seriwatanachai, R. Kiviranta, H. Saito, K. Yamana, L. Neff, A. Atfi, L. Coillard, D. Sitara, et al. 2010. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev. Cell. 19:533-546. doi:10.1016/j.devcel.2010.09. 008
7. de Frutos, C.A., R. Dacquin, S. Vega, P. Jurdic, I. Machuca-Gayet, and M.A. Nieto. 2009. Snail 1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J. 28:686-696. doi:10.1038/emboj.2009.23
8. Derynck, R., and R.J. Akhurst 2007. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat. Cell Biol. 9:1000-1004. doi:10.1038/ncb434 (Pubitemid 47338137)
9. Drissi, H., Q. Luc, R. Shakoori, S. Chuva De Sousa Lopes, J.Y Choi, A. Terry, M. Hu, S. Jones, J.C. Neil, J.B. Lian, et al. 2000. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 184:341-350. doi:10.1002/1097-4652(200009)184:3341:AID-JCP83.0.CO;2-Z
10. Ducy, P., and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1858-1869.
11. Ducy, P., R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty. 1997. Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell. 89:747-754. doi:10.1016/S0092-8674(00)80257-3
12. Galindo, M., J. Pratap, D.W. Young, H. Hovhannisyan, H.J. Im, J.Y. Choi, J.B. Lian, J.L. Stein, G.S. Stein, and A.J. van Wijnen. 2005. The bone-specific expression of Runx2 oscillates during the cell cycle to support a Gl-related antiproliferative function in osteoblasts. J. Biol. Chem. 280:20274-20285. doi:10.1074/jbc.M413665200 (Pubitemid 40776725)
13. Geoffroy, V., M. Kneissel, B. Fournier, A. Boyde, and P. Matthias. 2002. High bone resorption in adult aging transgenic mice overexpressing cbfal/runx2 in cells of the osteoblastic lineage. Mol. Cell. Biol. 22:6222-6233. doi: 10.1128/MCB.22.17.6222-6233.2002 (Pubitemid 34857841)
14. Giner, M., M.J. Montoya, M.A. Vazquez, M.J. Rios, R. Moruno, M.J. Miranda, and R. Perez-Cano. 2008. Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts. Horm. Metab. Res. 40:869-874. doi: 10.1055/s-0028-1082083
15. Harada, S., and G.A. Rodan. 2003. Control of osteoblast function and regulation of bone mass. Nature. 423:349-355. doi:10.1038/nature01660 (Pubitemid 40852710)
16. Hartmann, C. 2009. Transcriptional networks controlling skeletal development. Curr. Opin. Genet. Dev. 19:437-443. doi:10.1016/j.gde.2009.09.001
17. Hassan, M.Q., A. Javed, M.I. Morasso, J. Karlin, M. Montecino, A.J. van Wijnen, G.S. Stein, J.L. Stein, and J.B. Lian. 2004. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 24:9248-9261. doi:10.1128/MCB.24.20.9248-9261.2004 (Pubitemid 39313925)
18. Hassan, M.Q., S. Saini, J.A. Gordon, A.J. van Wijnen, M. Montecino, J.L. Stein, G.S. Stein, and J.B. Lian. 2009. Molecular switches involving homeodomain proteins, HOXA10 and RUNX2 regulate osteoblastogenesis. Cells Tissues Organs. 189:122-125. doi:10.1159/000151453
19. Hesslein, D.G., J.A. Fretz, Y Xi, T Nelson, S. Zhou, J.A. Lorenzo, D.G. Schatz, and M.C. Horowitz. 2009. Ebfl-dependent control of the osteoblast and adipocyte lineages. Bone. 44:537-546. doi:10.1016/j.bone.2008.11.021
20. Jensen, E.D., T.M. Schroeder, J. Bailey, R. Gopalakrishnan, and J.J. Westendorf. 2008. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J. BoneMiner. Res. 23:361-372. doi:10.1359/jbmr.071104 (Pubitemid 351304666)
21. Jensen, E.D., R. Gopalakrishnan, and J.J. Westendorf. 2009. Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. J. Biol. Chem. 284:2225-2234. doi:10.1074/jbc.M800586200
22. Kang, J.S., T Alliston, R. Delston, and R. Derynck. 2005. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24:2543-2555. doi:10.1038/sj.emboj.7600729 (Pubitemid 41076311)
23. Karsenty, G., H.M. Kronenberg, and C. Settembre. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-648. doi:10.1146/annurev. cellbio.042308.113308
24. Kolf, CM., E. Cho, and R.S. Tuan. 2007. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 9:204. doi:10.1186/ar2116 (Pubitemid 47288993)
25. Komori, T, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y Shimizu, R.T Bronson, Y.-H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755-764. doi:10.1016/S0092-8674(00)80258-5
26. Li, X., P. Liu, W. Liu, P. Maye, J. Zhang, Y Zhang, M. Hurley, C. Guo, A. Boskey, L. Sun, et al. 2005. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 37:945-952. doi:10.1038/ngl614
27. Lian, J.B., and G.S. Stein. 2003. Runx2/Cbfal: a multifunctional regulator of bone formation. Curr. Pharm. Des. 9:2677-2685. doi:10.2174/ 1381612033453659 (Pubitemid 37456017)
28. Lian, J.B., G.S. Stein, A. Javed, A.J. van Wijnen, J.L. Stein, M. Montecino, M.Q. Hassan, T Gaur, C.J. Lengner, and D.W. Young. 2006. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7:1-16. doi: 10.1007/s 11154-006-9001-5 (Pubitemid 44116389)
29. Liu, W., S. Toyosawa, T Furuichi, N. Kanatani, C. Yoshida, Y Liu, M. Himeno, S. Narai, A. Yamaguchi, andT Komori. 2001. Overexpression of Cbfal in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155:157-166. doi: 10.1083/jcb.200105052 (Pubitemid 34286216)
30. Lou, Y, A. Javed, S. Hussain, J. Colby, D. Frederick, J. Pratap, R. Xie, T Gaur, A.J. van Wijnen, S.N. Jones, et al. 2009. A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum. Mol. Genet. 18:556-568. doi:10.1093/hmg/ddn383
31. Moore, K.A., and I.R. Lemischka. 2006. Stem cells and their niches. Science. 311:1880-1885. doi:10.1126/science.H10542
32. Mundlos, S., F. Otto, C. Mundlos, J.B. Mulliken, A.S. Aylsworth, S. Albright, D. Lindhout, W.G. Cole, W. Henn, J.H. Knoll, et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:773-779. doi: 10.1016/S0092-8674(00)80260-3
33. Nakashima, K., X. Zhou, G. Kunkel, Z. Zhang, J.M. Deng, R.R. Behringer, and B. de Crombrugghe. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17-29. doi:10.1016/S0092-8674(01)00622-5 (Pubitemid 34137009)
34. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell G.W. Stamp, R.S. Beddington, S. Mundlos, B.R. Olsen, et al. 1997. Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:765-771. doi: 10.1016/S0092-8674(00)80259-7
35. Otto, F, H. Kanegane, and S. Mundlos. 2002. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum. Mutat. 19:209-216. doi: 10.1002/humu. 10043
36. Parntt, A.M., M.K. Drezner, FH. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610. doi:10.1002/jbmr. 5650020617
37. Razidlo, D.F, T.J. Whitney, M.E. Casper, M.E. McGee-Lawrence, B.A. Stensgard, X. Li, F.J. Secreto, S.K. Knutson, S.W. Hiebert, and J.J. Westendorf. 2010. Histone deacetylase 3 depletion in osteo/chondro-progenitor cells decreases bone density and increases marrow fat. PLoS One. 5:ell492. doi:10.1371/journal.pone.0011492
38. Rodda, S. J., and A.P. McMahon. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 133:3231-3244. doi: 10.1242/dev.02480 (Pubitemid 44404346)
39. Rowe, G.C., C.S. Choi, L. Neff, W.C. Home, G.I. Shulman, and R. Baron. 2009. Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology. 150:135-143. doi:10.1210/en.2008-0678
40. Sabatakos, G., N.A. Sims, J. Chen, K. Aoki, M.B. Kelz, M. Amling, Y. Bouali, K. Mukhopadhyay, K. Ford, E.J. Nestler, andR. Baron. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 6:985-990. doi: 10.1038/79683
41. Sabatakos, G., G.C. Rowe, M. Kveiborg, M. Wu, L. Neff, R. Chiusaroli, W.M. Philbrick, and R. Baron. 2008. Doubly truncated FosB iso-form (Delta2DeltaFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity. J. Bone Miner. Res. 23:584-595. doi:10.1359/jbmr.080110 (Pubitemid 351575013)
42. Schroeder, T.M., R.A. Kahler, X. Li, and J.J. Westendorf. 2004. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 279:41998-12007. doi: 10.1074/jbc.M403702200 (Pubitemid 39313651)
43. Stein, G.S., J.B. Lian, A.J. van Wijnen, J.L. Stein, M. Montecino, A. Javed, S.K. Zaidi, D.W. Young, J.-Y Choi, and S.M. Pockwinse. 2004. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene. 23:4315-4329. doi: 10.1038/sj.onc. 1207676
44. Turner, J., and M. Crossley. 1999. Mammalian Krtippel-like transcription factors: more than just a pretty finger. Trends Biochem. Sci. 24:236-240. doi:10.1016/S0968-0004(99)01406-l
45. van der Horst, G., S.M. van der Werf, H. Farih-Sips, R.L. van Bezooijen, C.W Lowik, and M. Karperien. 2005. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and-2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J. Bone Miner. Res. 20:1867-1877. doi:10.1359/JBMR.050614 (Pubitemid 41361889)
46. Westendorf, J.J., S.K. Zaidi, J.E. Cascino,R. Kahler, A.J. van Wijnen, J.B. Lian, M. Yoshida, G.S. Stein, andX. Li. 2002. Runx2 (Cbfal, AML-3) interacts with histone deacetylase 6 and represses the p21(CIPl/WAFl) promoter. Mol. Cell. Biol. 22:7982-7992. doi:10.1128/MCB.22.22.7982-7992.2002 (Pubitemid 35217306)
47. Wu, M., E. Hesse, F Morvan, J.P Zhang, D. Correa, G.C. Rowe, R. Kiviranta, L. Neff, W.M. Philbrick, W.C. Home, and R. Baron. 2009. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone. 44:528-536. doi:10.1016/j.bone.2008.11.011